Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-04-17

Clinical Trial Update: A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

View source ↗

Summary

A surveillance program update on detecting hepatitis B virus resistance to tenofovir in HIV-HBV co-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)

Snippet

Sponsor: Bayside Health | Conditions: HIV Infections, Hepatitis B Virus | Status: UNKNOWN